NDC 0121-2038 – Buprenorphine hydrochloride
Buprenorphine Hydrochloride 8 mg/1 · Tablet · Sublingual
Product NDC0121-2038
Product details
- Brand name
- Buprenorphine hydrochloride
- Generic name
- Buprenorphine hydrochloride
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Tablet
- Route
- Sublingual
- Marketing category
- ANDA · ANDA090622
- Marketed since
- October 12, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine Hydrochloride 8 mg/1
Uses, dosage, side effects and warnings for Buprenorphine Hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-2038-30 | 30 TABLET in 1 BOTTLE (0121-2038-30) | Oct 12, 2023 |
Other Buprenorphine Hydrochloride products
- 50090-7559 Buprenorphine Hydrochloride 8 mg/1 · Tablet · A-S Medication Solutions
- 72888-182 Buprenorphine Hydrochloride 2 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-183 Buprenorphine Hydrochloride 8 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-509 Buprenorphine Hydrochloride 4 mg/1 · Tablet · Advagen Pharma Ltd
- 72888-510 Buprenorphine Hydrochloride 12 mg/1 · Tablet · Advagen Pharma Ltd
- 0121-1019 Buprenorphine Hydrochloride 2 mg/1 · Tablet · PAI Holdings, LLC dba PAI Pharma
- 70518-4570 Buprenorphine Hydrochloride 2 mg/1 · Tablet · REMEDYREPACK INC.
- 70518-4571 Buprenorphine Hydrochloride 8 mg/1 · Tablet · REMEDYREPACK INC.
- 0143-9246 Buprenorphine Hydrochloride .324 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0409-2012 Buprenorphine Hydrochloride .3 mg/mL · Injection, Solution · Hospira, Inc.
- 42023-179 Buprenorphine Hydrochloride .324 mg/mL · Injection · Par Health USA, LLC
- 70069-027 Buprenorphine Hydrochloride .324 mg/mL · Injection · Somerset Therapeutics, LLC